Leah Wilson, MD
Oregon Health and Science University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Leah Wilson, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06676657 · Closed Loop Context Aware AIDOregon Health and Science University · recruiting · Type 1 Diabetes · principal investigator
- N/ANCT06422325 · Two Way Crossover Closed Loop Study Insulin vs Insulin and PramlintideOregon Health and Science University · completed · Type 1 Diabetes · principal investigator
- N/ANCT05799781 · Two Way Crossover Closed Loop MPC vs Control IQOregon Health and Science University · completed · Type 1 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Improving Glycemic Management in Patients with Type 1 Diabetes Using a Context-aware Automated Insulin Delivery SystemR01DK122583 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI Peter G Jacobs, LEAH MEGAN WILSON · fiscal years 2019 to 2022Named on NCT06676657
- Enabling Fully Automated Closed Loop Control in Type 1 Diabetes Through an Artificial Intelligence Meal Detection Algorithm and PramlintideR01DK129382 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI Peter G Jacobs · fiscal years 2021 to 2024Named on NCT06422325
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.